REKOMBINANTNYE POLIPEPTIDY KAK BIOMARKERY OTsENKI IMMUNOLOGIChESKOI EFFEKTIVNOSTI VAKTsINATsII ZhIVOY ChUMNOY VAKTsINOY U LYuDEY

Abstract



Full Text

Restricted Access

About the authors

A M Lyapina

V A Fedorova

Email: feodorovav@mail.ru

M A Khizhnyakova

M V Telepnev

V L Motin

References

  1. Медуницын Н. В. Вакцинология.- М.: Триада-Х, 2004.- 448с.
  2. Plotkin S. A. Correlates of Protection Induced by Vaccination // Clinical and Vaccine Immunology.- 2010.- Vol. 17, № 7.- P. 1055-1065.
  3. Feodorova V.A., Motin V. L. Plague vaccines // In: Vaccine Against Bacterial Biothreat Pathogens / eds. V. A. Feodorova and V. L. Motin.-Kerala, India: Research Signpost, 2011.- Ch. 8.- P. 175-233.
  4. Correlates of immunity elicited by live Yersinia pestis vaccine / V. L. Braciale, M. Nash, N. Sinha, I. V. Zudina, V. L. Motin // NIH: Frontiers in Research / ed. VS Georgiev.- Totowa, NJ: Humana Press, 2008.- Vol. 1, Ch. 49.- P. 473-480.
  5. Сравнительная частота обнаружения специфических антител к капсульному антигену и липополисахариду Yersinia pestis у привитых живой чумной вакциной / З. Л. Девдариани, В. А. Федорова, О. В. Громова, Т. М. Тараненко // Клиническая лабораторная диагностика. 1997.- № 4.- С. 39-41.
  6. Human immune response to a plague vaccine comprising recombinant F1 and V antigens / E. D. Williamson, H. C. Flick-Smith, C. Lebutt et al. // Infection and Immunity.- 2005.- Vol. 73 (6).- P. 3598-3608.
  7. Heath D. G., Anderson G.W Jr., Mauro J. et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine // Vaccine.- 1998.- Vol. 16 (11-12).- P. 1131-1137.

Statistics

Views

Abstract - 26

PDF (Russian) - 0

Cited-By


PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2012 Lyapina A.M., Fedorova V.A., Khizhnyakova M.A., Telepnev M.V., Motin V.L.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies